Skip to main content
Industry News
FDA approvals boost potential of liquid biopsies
11/6/2020

A growing number of FDA approvals have been granted to liquid biopsies, most recently Foundation Medicine's FoundationOne Liquid CDx test for various cancers and Guardant Health's platform as a companion diagnostic for a subtype of non-small cell lung cancer.

Full Story: